Temozolomide

4 registered clinical trials studyying Temozolomide — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma NCT05512481	Peking University Cancer Hospital & Institute	Phase 2
Unknown	Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma NCT06279767	The First Affiliated Hospital with Nanjing Medical University	Phase 1 / Phase 2
Terminated	Trial in Low Grade Glioma Patients: Wait or Treat NCT03763422	European Organisation for Research and Treatment of Cancer - EORTC	Phase 3
Completed	TEMCAP in Grade 3 and Low Ki-67 Gastroenteropancreatic Neuroendocrine Tumors NCT03079440	Asan Medical Center	Phase 2